John Lent
@Bourne Lent Asset Management Inc
Latest period2024 - Q4ReportedManaged Assets$262.333MTotal holdings61
Assets growth rate-0.45%Assets growth rate (2-Q avg)0.3%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Bourne Lent Asset Management Inc's 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 61 positions.
Assets under management
The assets under management (AUM) of Bourne Lent Asset Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 262.333M in assets, with a quarterly growth rate of -0.45% and a 2-quarter average growth rate of 0.3%. The portfolio is managed by John Lent, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VVisa Inc
| 0.97% | $2.539M 8,034 shares@ $316.04 avg price | Increased 18.15% |
BKNGBooking Holdings Inc
| 0.86% | $2.246M 452 shares@ $4968.43 avg price | |
NVDANvidia Corporation
| 0.83% | $2.174M 16,190 shares@ $134.29 avg price | |
JNJJohnson & Johnson
| 0.8% | $2.078M 14,366 shares@ $144.63 avg price | Increased 1.42% |
SYMSymbotic Inc
| 0.79% | $2.068M 87,210 shares@ $23.71 avg price | Increased 34.78% |
PACBPacific Biosciences Calif In
| 0.66% | $1.727M 943,755 shares@ $1.84 avg price | Decreased -1.13% |
NTRNutrien Ltd
| 0.58% | $1.518M 33,932 shares@ $44.75 avg price | Decreased -8.37% |
LHXL3harris Technologies Inc
| 0.56% | $1.459M 6,940 shares@ $210.28 avg price | Decreased -0.71% |
BSXBoston Scientific Corp
| 0.55% | $1.424M 15,948 shares@ $89.32 avg price | Decreased -10.24% |
TROWPrice T Rowe Group Inc
| 0.4% | $1.025M 9,067 shares@ $113.09 avg price |